Ondansetron for irritable bowel syndrome
Metadata[+] Show full item record
This randomized, double-blind, placebo-controlled crossover study compared ondansetron with placebo in 120 patients aged 18 to 75 years with irritable bowel syndrome with diarrhea (IBS-D) from clinics in the United Kingdom.
Evidence-based practice 18, no. 02 (2015): 4